Researchers have identified diagnostic microRNA panels in whole blood that had the ability to distinguish, to some degree, patients with and without pancreatic cancer, according to a new study.
The presence of gene mutations associated with pancreatic cancer could potentially be determined with a simple blood test. This appears possible because of the discovery that tiny particles the size of viruses called exosomes, which are shed by cancer cells into the blood, contain the entire genetic blueprint of cancer cells.
Panels of microRNA expression can potentially distinguish pancreatic cancer from healthy controls, according to a study.
Combination vaccine significantly improves overall survival in pancreatic cancer, compared with single-component vaccine.
Pancreatic cancer death rates in whites and blacks have gone in opposite directions over the past several decades in the United States, with the direction reversing in each ethnicity during those years. Researchers involved with this new study say the rising and falling rates are largely unexplainable by known risk factors.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|